Gelonghui May 16 δΈ¨ Jiabiyou (688089fufu4dslot.SH) said on the investor interaction platformfufu4dslotWith technological innovation as the fundamental driving force, the company has opened up the entire technical chain of synthetic biology and gradually formedfufu4dslotIt has a biological data analysis and processing platform with computational biology and bioinformatics as its core technical capabilities, a biosynthesis platform with genetic engineering, metabolic engineering, enzyme engineering, and cell engineering as its core technical capabilities, and a functional verification platform with cell biology, biomedicine, and multi-dimensional omic visualization analysis as its core capabilities. From product development to application technology, the company's synthetic biology R & D technical capabilities have been further improved. Based on synthetic biology technology, the company has currently developed a series of HMO products.
